A Phase 1 interventional study of L Arginine and Sodium Fluoride in Caries,Dental, sponsored by Colgate Palmolive. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-02.
Sponsored by Colgate Palmolive · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 193 studies in Dental Caries with a site in United States — 16 open to participants now, 19 under way, 3 of them phase 3. Dental Caries · United States.
Among the 193 studies in Dental Caries with a site in United States, this one is the 135th largest by enrollment of the 168 interventional ones that give a count, is one of 7 that started in 2023, is one of 13 in phase 1, and was the 166th registered.
1,174 studies on the registry are indexed under Dental Caries; 209 are open to participants now.
Browse Dental Caries studies →16 of the 193 studies in Dental Caries with a site in United States are open now. Recruiting first, the newest first:
University of Michigan · Sites in United States
Ages 8–12
University of Michigan · Sites in United States
Ages 18–99
A.T. Still University of Health Sciences · Sites in United States
Ages 6–10
University of Pennsylvania · Sites in United States
Ages 5–13 · Healthy volunteers
University of Massachusetts, Worcester · Sites in United States
Ages 12 mo–45 yrs · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
193 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 19 · Phase 3 23 · Phase 4 4
First in 1996; this study’s year is marked. 7 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 29 is below the median of 60 across 967 interventional studies indexed under Dental Caries.
Median enrollment 60 across the 168 interventional studies, 264 across the 25 observational. Of the 166 that completed or were terminated, 68 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
44 of 193 have an industry lead sponsor. The 10 most frequent:
Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
Colgate Palmolive has 8 studies filed under Dental Caries — fewer than ten, so there is no comparison to draw.
6 of the studies in Dental Caries with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07124533Phase 3Loma Linda UniversityEffectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences | 2026-12 |
| NCT06588725Vanderbilt University Medical CenterBrief Interventions to Improve Behavior Outcomes and Prevent Cavities | 2027-01 |
| NCT05756413University of IowaBirth to Three - Cavity Free | 2027-03-31 |
| NCT07648212University of MichiganArtificial Intelligence (AI) for Proximal Caries Detection and Its Impact on Treatment Threshold | 2027-05 |
| NCT06714929Virginia Commonwealth UniversityAdvancing Water Security: A Community Participatory School-Based Hydration Intervention | 2027-05-31 |
Add all 6 to your calendar (.ics) → With an account.
Among the 193 studies in Dental Caries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Pharmacokinetic (PK) study of L-arginine after exaggerated oral use of the novel dentifrice product COL101 after repeated daily applications in healthy adult subjects.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
toothpaste containing 8% L-arginine
Drug: L Arginine · Drug: Sodium Fluoride
toothpaste containing 0.24% sodium fluoride
Drug: L Arginine · Drug: Sodium Fluoride
toothpaste
toothpaste
Arginine in blood
Measurement of arginine in blood after oral brushing
Time frame: Day 1 for 24 hours
Arginine in blood
Measurement of arginine in blood after oral brushing
Time frame: Day 7 for 24 hours
Arginine in blood
Measurement of arginine in blood after oral brushing
Time frame: Day 10 for 24 hours
Arginine in blood
Measurement of arginine in blood after oral brushing
Time frame: Day 16 for 24 hours
Plan to share: No
No publications or documents are linked to this record.
Ran from Nov 2023 to primary completion in Dec 2023, 0 months.
Of 15 phase 1 interventional studies under Dental Caries, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 18. This study's 0 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Arginine